Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 公共衛生碩士學位學程
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22141
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor楊銘欽(Ming-Chin Yang)
dc.contributor.authorChun-Fu Kuoen
dc.contributor.author郭純甫zh_TW
dc.date.accessioned2021-06-08T04:04:42Z-
dc.date.copyright2018-09-04
dc.date.issued2018
dc.date.submitted2018-07-31
dc.identifier.citation台灣胸腔暨重症加護醫學會. (2012). 慢性阻塞性肺病(慢阻肺)2012診治指引.
衛生福利部. (2014). 103年死因統計結果分析.
衛生福利部. (2015). 104年死因統計結果分析.
紀崑山(2016)。慢性阻塞性肺病急性惡化患者營養不良狀態及復食症候群之研究。靜宜大學食品營養學系博士論文。
ALA. (2013). Trends in COPD (Chronic Bronchitis and Emphysema):Morbidity and Mortality.
Bai, J.-W., Mao, B., Yang, W.-L., Liang, S., Lu, H.-W., & Xu, J.-F. (2016). Asthma–COPD overlap syndrome showed more exacerbations however lower mortality than COPD.
Barnes, P. J. (2008). Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc, 5(8), 857-864. doi:10.1513/pats.200807-069TH
Breyer, M. K., Spruit, M. A., Hanson, C. K., Franssen, F. M., Vanfleteren, L. E., Groenen, M. T., . . . Rutten, E. P. (2014). Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS One, 9(6), e98013. doi:10.1371/journal.pone.0098013
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., . . . ZuWallack, R. (2004). Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal, 23(6), 932-946. doi:10.1183/09031936.04.00014304
Cheng, S. L., Chan, M. C., Wang, C. C., Lin, C. H., Wang, H. C., Hsu, J. Y., . . . Yu, C. J. (2015). COPD in Taiwan: a National Epidemiology Survey. Int J Chron Obstruct Pulmon Dis, 10, 2459-2467. doi:10.2147/COPD.S89672
Corsonello, A., Incalzi, R. A., Pistelli, R., Pedone, C., Bustacchini, S., & Lattanzio, F. (2011). Comorbidities of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine, 17, S21-S28.
Dewan, N. A., Rafique, S., Kanwar, B., Satpathy, H., Ryschon, K., Tillotson, G. S., & Niederman, M. S. (2000). Acute Exacerbation of COPD. Chest, 117(3), 662-671. doi:10.1378/chest.117.3.662
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., . . . Group, B. C. (2012). Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 186(2), 155-161. doi:10.1164/rccm.201201-0034OC
Fukuchi, Y., Nishimura, M., Ichinose, M., Adachi, M., Nagai, A., Kuriyama, T., . . . Zaher, C. (2004). COPD in Japan: The Nippon COPD Epidemiology Study. Respirology, 9(4), 458-465. doi:10.1111/j.1440-1843.2004.00637.x
G, S. K., P, D., K, S., & T, K. K. (2017). ASTHMA-COPD OVERLAP SYNDROME (ACOS) - AN UNDER DIAGNOSED CLINICAL CONDITION AMONG GERIATRICS.
Ghoorah, K., De Soyza, A., & Kunadian, V. (2013). Increased cardiovascular risk in patients with chronic obstructive pulmonary disease and the potential mechanisms linking the two conditions: a review. Cardiol Rev, 21(4), 196-202. doi:10.1097/CRD.0b013e318279e907
GOLD. (2016). Global Strategy for Diagnosis, Management, and Prevention of COPD.
Hasegawa, K., Tsugawa, Y., Tsai, C. L., Brown, D. F. M., & Camargo, C. A. (2014). Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease. Respiratory Research, 15, 13. doi:10.1186/1465-9921-15-40
Hong, J. S., Kang, H. C., & Kim, J. (2010). Continuity of care for elderly patients with diabetes mellitus, hypertension, asthma, and chronic obstructive pulmonary disease in Korea. J Korean Med Sci, 25(9), 1259-1271. doi:10.3346/jkms.2010.25.9.1259
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Mullerova, H., Tal-Singer, R., . . . Evaluation, C. L. (2010). Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 363(12), 1128-1138. doi:10.1056/NEJMoa0909883
Ke, X., Marvel, J., Yu, T. C., Wertz, D., Geremakis, C., Wang, L., . . . Mannino, D. M. (2016). Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD. Int J Chron Obstruct Pulmon Dis, 11, 1689-1703. doi:10.2147/COPD.S108967
KESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B., & WEITZENBLUM, E. (1999). Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease.
Laforest, L., Roche, N., Devouassoux, G., Belhassen, M., Chouaid, C., Ginoux, M., & Van Ganse, E. (2016). Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respir Med, 117, 33-39. doi:10.1016/j.rmed.2016.05.019
Lainscak, M., von Haehling, S., Doehner, W., Sarc, I., Jeric, T., Ziherl, K., . . . Suskovic, S. (2011). Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle, 2(2), 81-86. doi:10.1007/s13539-011-0023-9
Laurin, C., Labrecque, M., Dupuis, G., Bacon, S. L., Cartier, A., & Lavoie, K. L. (2009). Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med, 71(6), 667-674. doi:10.1097/PSY.0b013e3181a82849
Lee, C. T., Mao, I. C., Lin, C. H., Lin, S. H., & Hsieh, M. C. (2013). Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study. Eur J Clin Invest, 43(11), 1113-1119. doi:10.1111/eci.12147
Liao, W. C., Lin, C. L., Chang, S. N., Tu, C. Y., & Kao, C. H. (2015). The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study. Eur J Neurol, 22(2), 334-340. doi:10.1111/ene.12573
Lim, S., Lam, D. C., Muttalif, A. R., Yunus, F., Wongtim, S., Lan le, T. T., . . . de Guia, T. (2015). Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med, 14(1), 4. doi:10.1186/s12930-015-0020-9
Lindberg, A., Bjerg, A., Ronmark, E., Larsson, L. G., & Lundback, B. (2007). Prevalence and underdiagnosis of COPD by disease severity and attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies (vol 100, pg 264, 2006). Respiratory Medicine, 101(12), 2569-2569. doi:10.1016/j.rmed.2007.07.019
Maclay, J. D., & MacNee, W. (2013). Cardiovascular disease in COPD: mechanisms. Chest, 143(3), 798-807. doi:10.1378/chest.12-0938
Raherison, C. (2010). Epidemiology of asthma and COPD in France. Revue Des Maladies Respiratoires, 27(2), 108-109. doi:10.1016/j.rmr.2010.01.012
Soler-Cataluna, J. J., Martinez-Garcia, M. A., Roman Sanchez, P., Salcedo, E., Navarro, M., & Ochando, R. (2005). Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax, 60(11), 925-931. doi:10.1136/thx.2005.040527
Suissa, S., Dell'Aniello, S., & Ernst, P. (2012). Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax, 67(11), 957-963. doi:10.1136/thoraxjnl-2011-201518
Tan., W. C., Seale., J. P., Charaoenratanakul., S., Guia., T. d., Ip., M., Mahayiddin., A., . . . Schau., B. (2002). COPD prevalence in 12 Asia-Pacific countries and regions_ projections based on the COPD prevalence estimation model.
van Boven, J. F. M., Roman-Rodriguez, M., Palmer, J. F., Toledo-Pons, N., Cosio, B. G., & Soriano, J. B. (2016). Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life. Chest, 149(4), 1011-1020. doi:10.1016/j.chest.2015.12.002
Wakabayashi, R., Motegi, T., Yamada, K., Ishii, T., Gemma, A., & Kida, K. (2011). Presence of in-home caregiver and health outcomes of older adults with chronic obstructive pulmonary disease. J Am Geriatr Soc, 59(1), 44-49. doi:10.1111/j.1532-5415.2010.03222.x
Walters, J. A., Tan, D. J., White, C. J., Gibson, P. G., Wood-Baker, R., & Walters, E. H. (2014). Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev(9), CD001288. doi:10.1002/14651858.CD001288.pub4
Yu-Feng Wei, P.-H. K., Ying-Huang Tsai,3Chi-Wei Tao, Shih-Lung Cheng, Chao-Hsien Lee, Yao-Kuang Wu, Ning-Hung Chen, Wu-Huei Hsu, Jeng-Yuan Hsu,Ming-Shian Lin, and Chin-Chou Wang. ( 2015). Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort. doi:10.2147/COPD.S88114
台灣胸腔暨重症加護醫學會. (2012). 慢性阻塞性肺病(慢阻肺)2012診治指引.
吳肖琪, & 陳欣. (2015). 老年照護醫師人力的未來發展.
林宜柏, & 吳肖琪. (2015). 慢性阻塞性肺病門診照護連續性之相關因素探討. 台灣衛誌, 34, 404-411.
衛生福利部. (2014). 103年死因統計結果分析.
衛生福利部. (2015). 104年死因統計結果分析.
衛生福利部國民健康署, 臺., 台灣胸腔暨重加護醫學會,臺灣實證醫學會. (2017). 台灣肺阻塞臨床照護指引.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/22141-
dc.description.abstract背景:近年來,慢性阻塞性肺病(Chronic Obstructive Pulmonary Disease,以下簡稱COPD)的盛行率及死亡率日益提高,健保署亦於2017年新增「慢性阻塞性肺病醫療給付改善方案」,希望藉此提高照護品質、減少病患急性發作次數。
目的:本研究期望瞭解持續於實習醫院接受照護之COPD病患,其急性發作相關的個人特質及風險因素,以作為後續照護及管理上的參考。
方法:本研究為次級資料庫分析,以回溯性世代方式進行。並以卡方檢定、T檢定、ANOVA及存活分析探討收案對象個人特質、疾病嚴重度、共病症與其急性發作機率、次數及風險之相關性。
結果:研究對象共293位COPD病人,其中101人(34.5%)在追蹤期間有急性發作至少1次。疾病嚴重度越高、BMI越低,其輕、中、重度急性發作機率及次數均較高,且急性發作風險亦較高;有糖尿病或高血壓共病症者,其急性發作機率及次數雖較高,但未達顯著相關。而年齡則與急性發作風險成正比,結果顯示年齡每增加一歲,急性發作風險比增加0.023倍 (95%CI, 1.00-1.04);BMI則與急性發作風險成反比,BMI每增加1單位,急性發作風險比減少0.059倍 (95%CI, 0.90-0.99);而BMI過重族群(24≦BMI<27)其急性發作風險為過輕者之0.365倍 (95%CI, 0.16-0.84)。在疾病嚴重度因素中,相對於最輕微的mild,其急性發作風險亦隨嚴重度提高而提升:中度提高1.192倍(95%CI, 0.725-1.958),重度提高2.671倍 (95%CI, 1.528-4.671),極重度提高4.101倍 (95%CI, 1.582-10.634)。
結論:透過本篇研究了解院內COPD病患急性發作之相關因素,建議本次實習之醫院未來可參考本研究之發現,結合相關資源,以提供病患完整且高品質的照護,降低COPD急性發作的風險。
zh_TW
dc.description.abstractBackground: The prevalence and mortality rates of Chronic Obstructive Pulmonary Disease (COPD) have been increasing in recent years. In order to prevent frequent acute exacerbation (AE) and enhance the quality of health care, the National Health Insurance Administration has implemented “Chronic Obstructive Pulmonary Disease Pay-for performance Program” in 2017.
Purpose: The purpose of this study is to explore the related factors of acute exacerbation in the practicum hospital to provide information for caring and management of COPD patients.
Method: This study is a secondary data analysis study using a retrospective cohort from the practicum hospital. We used Chi-Squared test, Student’s t-test, ANOVA test, Kaplan-Meier Survival Curve and Cox Proportional Hazard Regression to analyze the correlation between personal characteristics, severity of COPD, comorbidities and probability of having AEs, number of AEs, and related risk factors.
Results: A total of 293 COPD patients were included in the study and 101(34.5%) of them had at least one acute exacerbation during research period. The results indicate that probability, number and risk of having acute exacerbation became more frequent and higher as the severity of COPD increased and BMI decreased. Patients with diabetes and hypertension also have higher probability and more frequent acute exacerbation than patients without those two comorbidities. The risk of acute exacerbation increased 1.023 times (95%CI, 1.00-1.04) as age increase by 1 year, and increase 0.941 times (95%CI, 0.90-0.99) as BMI increased by 1 unit. Compared to mild, the probability of having AEs also increases: moderate by 1.192 times (95%CI, 0.725-1.958); severe by 2.671 times (95%CI, 1.528-4.671); and very severe increase by 4.101 times (95%CI, 1.582-10.634).
Conclusion: Through the results of this research we can understand that the factors associate with acute exacerbation of COPD patients in the practicum hospital. In order to reduce the probability of having AEs, it is recommended that the practicum hospital can integrate related resources to provide more comprehensive and higher quality care in the future.
en
dc.description.provenanceMade available in DSpace on 2021-06-08T04:04:42Z (GMT). No. of bitstreams: 1
ntu-107-R03847041-1.pdf: 4583347 bytes, checksum: f9da6e6eb5829fa72d5bb76985b52c19 (MD5)
Previous issue date: 2018
en
dc.description.tableofcontents論文口試委員審定書 I
致 謝 II
中文摘要 III
ABSTRACT IV
第一章 導論 1
第一節、實習單位特色與簡介 1
第二節、研究動機與目的 2
第二章 文獻回顧 5
第一節、慢性阻塞性肺病(CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COPD) 5
第二節、慢性阻塞性肺病(COPD)的盛行率與致死率 6
第三節、慢性阻塞性肺病(COPD)的疾病負擔 9
第四節、與慢性阻塞性肺病急性發作相關之因素 10
第三章 研究設計與方法 16
第一節、研究設計與架構 16
第二節、研究假說 16
第三節、資料來源及研究對象 17
第四節、變項定義與資料蒐集 18
第五節、統計方法 21
第四章 結果 22
第一節、研究對象資料分析 23
第二節、研究對象急性發作與否之相關性分析 26
第三節、研究對象急性發作次數之相關性分析 35
第四節、研究對象首次發生急性發作風險分析 44
第五節、以COX PROPORTIONAL HAZARDS MODEL探討急性發作風險比率 52
第五章 討論 56
第一節、研究資料之品質 56
第二節、假說驗證結果 56
第三節、研究限制 61
第六章 結論與建議 62
第一節、結論 62
第二節、建議 63
參考文獻 64
附錄 68
dc.language.isozh-TW
dc.subject慢性阻塞性肺病zh_TW
dc.subject風險因素zh_TW
dc.subject急性發作zh_TW
dc.subjectrisk factorsen
dc.subjectacute exacerbationen
dc.subjectChronic obstructive pulmonary diseaseen
dc.title某醫學中心慢性阻塞性肺病病人急性發作之相關因素探討zh_TW
dc.titleFactors Associated with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Medical Centeren
dc.typeThesis
dc.date.schoolyear106-2
dc.description.degree碩士
dc.contributor.coadvisor彭殿王(Diahn-Warng Perng)
dc.contributor.oralexamcommittee董鈺琪(Yu-Chi Tung)
dc.subject.keyword慢性阻塞性肺病,急性發作,風險因素,zh_TW
dc.subject.keywordChronic obstructive pulmonary disease,acute exacerbation,risk factors,en
dc.relation.page72
dc.identifier.doi10.6342/NTU201802181
dc.rights.note未授權
dc.date.accepted2018-07-31
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept公共衛生碩士學位學程zh_TW
顯示於系所單位:公共衛生碩士學位學程

文件中的檔案:
檔案 大小格式 
ntu-107-1.pdf
  未授權公開取用
4.48 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved